BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $782,000 | -31.9% | 13,094 | -33.4% | 0.00% | 0.0% |
Q3 2018 | $1,149,000 | +54.0% | 19,646 | +18.1% | 0.00% | +50.0% |
Q2 2018 | $746,000 | -6.4% | 16,635 | -7.5% | 0.00% | -33.3% |
Q1 2018 | $797,000 | +12.7% | 17,976 | +10.1% | 0.00% | +50.0% |
Q4 2017 | $707,000 | +118.9% | 16,325 | +135.1% | 0.00% | +100.0% |
Q3 2017 | $323,000 | -28.4% | 6,943 | -23.7% | 0.00% | -50.0% |
Q2 2017 | $451,000 | -47.4% | 9,105 | -41.9% | 0.00% | -33.3% |
Q1 2017 | $858,000 | -45.0% | 15,658 | -44.1% | 0.00% | -50.0% |
Q4 2016 | $1,561,000 | -17.9% | 28,027 | -32.7% | 0.01% | -14.3% |
Q3 2016 | $1,902,000 | +19.8% | 41,640 | +4.8% | 0.01% | 0.0% |
Q2 2016 | $1,588,000 | +0.7% | 39,751 | -12.2% | 0.01% | -12.5% |
Q1 2016 | $1,577,000 | +150.3% | 45,292 | +208.7% | 0.01% | +166.7% |
Q4 2015 | $630,000 | -58.3% | 14,672 | -49.9% | 0.00% | -57.1% |
Q2 2015 | $1,512,000 | +96.4% | 29,297 | +48.9% | 0.01% | +75.0% |
Q1 2015 | $770,000 | -46.5% | 19,679 | -47.2% | 0.00% | -50.0% |
Q4 2014 | $1,439,000 | +267.1% | 37,266 | +235.7% | 0.01% | +300.0% |
Q3 2014 | $392,000 | +66.1% | 11,100 | -8.3% | 0.00% | 0.0% |
Q3 2013 | $236,000 | – | 12,111 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 385,954 | $16,723,000 | 10.02% |
JW Asset Management, LLC | 73,649 | $3,191,000 | 3.40% |
Elk Creek Partners, LLC | 168,714 | $7,310,000 | 0.43% |
NORTHPOINTE CAPITAL LLC | 80,710 | $3,497,000 | 0.39% |
Ativo Capital Management LLC | 33,096 | $1,434,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 155,318 | $6,730,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 17,406 | $754,000 | 0.20% |
Matarin Capital Management, LLC | 48,952 | $2,121,090,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 4,324 | $187,000 | 0.05% |
Summit Trail Advisors, LLC | 6,797 | $295,000 | 0.04% |